Volume 9, Issue 10 e0847
CASE REPORT
Open Access

A case of pulmonary arterial hypertension with V/Q SPECT/CT that showed localized uptake of 99mTc just below the pleura and a unique distribution

Yuri Suzuki

Yuri Suzuki

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Ayumi Sekine

Corresponding Author

Ayumi Sekine

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Correspondence

Ayumi Sekine, Department of Respirology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba 260-8670, Japan.

Email: [email protected]

Search for more papers by this author
Akira Nishiyama

Akira Nishiyama

Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Toshihiko Sugiura

Toshihiko Sugiura

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Nobuhiro Tanabe

Nobuhiro Tanabe

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Department of Pulmonary Hypertension Center, Chibaken Saiseikai Narashino Hospital, Narashino, Japan

Search for more papers by this author
Yuri Isaka

Yuri Isaka

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Yaeko Hashimoto

Yaeko Hashimoto

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Tadasu Okaya

Tadasu Okaya

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Ayaka Kuriyama

Ayaka Kuriyama

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Jun Nagata

Jun Nagata

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Department of Pulmonary Hypertension Center, Chibaken Saiseikai Narashino Hospital, Narashino, Japan

Search for more papers by this author
Ayako Shigeta

Ayako Shigeta

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Seiichiro Sakao

Seiichiro Sakao

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Koichiro Tatsumi

Koichiro Tatsumi

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
Takuji Suzuki

Takuji Suzuki

Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan

Search for more papers by this author
First published: 14 September 2021
Associate Editor: Arata Azuma
Funding information Ministry of Education, Culture, Sports, Science and Technology, Grant/Award Number: 19K17626

Abstract

Pulmonary hypertension (PH) is a life-threatening disorder, which originates from various aetiologies. Ventilation–perfusion (V/Q) scanning is commonly used to evaluate the differential diagnosis of PH. Meanwhile, previous studies have shown that single-photon emission computed tomography (SPECT)/CT imaging can provide a more detailed analysis for the assessment of pulmonary blood flow. However, there is insufficient evidence supporting the merits of V/Q SPECT/CT image data in detecting pulmonary vascular disease. Here, we report a case of pulmonary arterial hypertension with localized accumulation and peculiar distribution just below the pleura on V/Q SPECT/CT. Our finding is unique, and it suggests that V/Q SPECT/CT image data might be useful to detect blood flow not only in cases of pulmonary embolism, but also in the more commonly encountered PH.

INTRODUCTION

Pulmonary hypertension (PH) is a progressive, fatal disease characterized by an increase in mean pulmonary artery pressure (PAP) and pulmonary vascular resistance. PH originates from diverse aetiologies and is categorized into five groups.1

Various imaging tests are recommended for the evaluation of PH, and they can be used for three main purposes: (1) suspecting the presence of PH, (2) determining the aetiology of the disease and (3) evaluating the prognosis and response to therapy.2

Considering the aetiology of PH, ventilation–perfusion (V/Q) scanning is often useful for screening patients with chronic thromboembolic PH (CTEPH) and distinguishing it from others.3 According to the 6th World Symposium on Pulmonary Hypertension, it is recommended that V/Q scanning should be performed in patients with high or intermediate risk of PH.4

V/Q single-photon emission computed tomography (SPECT) lung scanning could make it easier to avoid segmental overlap and define the size and location of perfusion defects in each segment.5 Moreover, dual-modality techniques with hybrid SPECT/CT pulmonary imaging can improve the specificity of V/Q SPECT by identifying lung disease in patients with perfusion abnormalities.4 However, there is insufficient evidence for the detection of pulmonary vascular disease using SPECT/CT image data.

Here, we report a case of PH with unique SPECT/CT imaging, showing localized subpleural perfusion.

CASE REPORT

A 46-year-old woman with chest pain was diagnosed with a right spontaneous pneumothorax at a former hospital. She was naturally healthy; however, 3 years before this presentation, she developed a right pneumothorax for the first time. Afterwards, she experienced recurrence during menstruation, several times. Wedge resectomy of the right upper lung was performed under general anaesthesia. Microscopically, endometrial stromal cells were observed in the visceral pleura, which led to the final diagnosis of catamenial pneumothorax. After the operation, the cardiac silhouette of the chest radiograph gradually enlarged. As ultrasonographic cardiography showed the trans-tricuspid pressure gradient as 75 mmHg and right ventricular systolic pressure as 88 mmHg, she was referred to our hospital on suspicion of PH. The patient had a history of endometriosis. She did not smoke tobacco or drink alcohol. There was no family history of pulmonary or cardiac disease.

The clinical cardiac functional status was New York Heart Association (NYHA) II. There was an accentuated pulmonic component of second heart sounds.

The plasma level of brain natriuretic peptide was 87.9 pg/ml (reference range, <18.4). Results of blood count and coagulation tests were normal. Other test results are shown in Table 1.

TABLE 1. Peripheral blood examination
Complete blood count
WBC 4400/μl
Neutrophil 58.7%
Eosinophil 0.5%
Basophil 1.6%
Lymphocyte 32.9%
Monocyte 6.3%
RBC 509 × 104/μl
Hb 14.0 g/dl
Hematocrit 42.6%
Plt 29.7 × 104/μl
Coagulation
Prothrombin time 10.7 s
International normalized ratio of prothrombin time 1.01
Activated partial thromboplastion time 33.4 s
d-dimer 0.8 μg/ml
Biochemistry
Total protein 7.9 g/dl
Na 139 mEq/L
K 4.1 mEq/L
Cl 108 mEq/L
Urea nitrogen 11 mg/dl
Cre 0.7 mg/dl
Uric acid 4.3 mg/dl
T-Bil 0.8 mg/dl
Aspartate aminotransferase 20 IU/L
Alanine aminotransferase 9 IU/L
Alkaline phosphatase 173 IU/L
γ-Glutamyl transpeptidase 13 IU/L
LDH 217 IU/L
Creatinine kinase 68 IU/L
CRP 0.01 mg/dl
Endocrine
FT4 1.05 ng/dl
Thyroid Stimulating Hormone 1.97 μU/ml
BNP 87.9 pg/ml
Immune system
Antinuclear Antibody ×80
Anti-dsDNA antibody <2.0 U/ml
Anti-SS-A antibody 0.7 U/ml
Anti-SS-B antibody 1.0 U/ml
Anti-ribonucleoprotein antibody 0.7 U/ml
Anti-centromere antibody 0.6 U/ml
Anti-Jo-1 antibody (−)
Anti-Scl 70 antibody (−)
Myeloperoxidase-anti-neutrophil cytoplasmic antibody <1.0 EU
Proteinase-3-anti-neutrophil cytoplasmic antibody <1.0 EU
  • Abbreviations: BNP, brain natriuretic peptide; CRP, C-reactive protein; Hb, haemoglobin; LDH, lactate dehydrogenase; Plt, platelet; RBC, red blood cell; WBC, White blood cell.

A frontal chest radiograph showed enlargement of the left and right pulmonary artery diameter and right ventricle (Figure 1A). Axial CT scans of the chest showed no notable findings in the lung parenchyma (Figure 1B). Histopathologically, the operated lung showed stenotic pulmonary arterioles with intimal thickening and medial hypertrophy, which is classified as Grade 3 in Heath–Edwards classification (Figure 1C).

Details are in the caption following the image
(A) Frontal chest radiograph shows enlargement of the left and right pulmonary artery diameter and right ventricle. (B) Axial computed tomography scans of the chest show no notable findings in the lung parenchyma. (C) Histopathological findings of the lung tissue (Elastica Van Gieson staining) show stenotic pulmonary arterioles with intimal thickening and medial hypertrophy

Perfusion lung scan was performed with technetium 99m (99mTc)-labelled macroaggregated albumin (MAA) to detect CTEPH, and it showed a mottled pattern in the planar view (Figure 2A). Ventilation scan was performed with krypton 81m, which revealed no notable findings. At the same time, SPECT/CT imaging was performed. Interestingly, the uptake of 99mTc was seen as localized accumulation just below the subpleura at the bilateral lungs (Figure 2B).

Details are in the caption following the image
(A) Perfusion lung scan which is performed with technetium 99m (99mTc)-labelled macroaggregated albumin (MAA) shows a mottled pattern in the planar view. Ventilation scan which is performed with krypton 81m (81mKr) reveals no notable findings. Upper left: 99mTc-MAA anterior image, upper right: 99mTc-MAA posterior image, lower left: 81mKr anterior image, lower right: 81mKr posterior image. (B) Single-photon emission computed tomography (SPECT)/CT images show localized uptake of 99mTc just below the pleura at bilateral lungs. (C) CT angiography reports a 16-mm defect hole in the atrial septum. (D) The pulmonary selective wedge angiography shows hypoplasia of the right pulmonary artery. (E) The SPECT/CT images of a typical case of idiopathic pulmonary arterial hypertension patient without atrial septal defect, endometriosis and the history of pneumothorax or thoracic surgery

Right heart catheterization was performed, and it showed step-down of SaO2 (arterial oxygen saturation; superior vena cava 63.4% and right atrium 74.4%) and high PAP of 97/26 (51) mmHg. Pulmonary capillary wedge pressure was normal (6 mmHg). Supplemental results are shown in Table 2.

TABLE 2. Haemodynamic parameters obtained from cardiac catheterization
On admission Four months later
Room air Room air 100% O₂
PAP, mmHg 97/26 (51) 68/20 (38) 62/11 (32)
Mean RAP, mmHg 6
Mean PCWP, mmHg 6 5 5
AoP, mmHg 117/73 (83) 119/69 (87)
Qp, L/min 8.22 8.40
Qs, L/min 5.78 5.34
Qp/Qs 1.423 1.572
PVR, Wood units 8.44 4.01 3.21
CO, L/min 5.33 8.22 8.4
Shunt ratio, % 34.48 42.00
Oxygen saturation, %
Superior vena cava 63.4
Inferior vena cava 54.2
Right atrium 74.4
Right ventricle 72.7
Pulmonary artery 72.6
  • Abbreviations: AoP, aorta pressure; CO, cardiac output; Qp, pulmonary blood flow; Qs, systemic blood flow; PAP, pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance; RAP, right atrium pressure.

Later, the patient underwent CT angiography, reporting a 16-mm defect hole in the atrial septum (Figure 2C). The shunt hole was relatively small, but we diagnosed that it led to pulmonary arterial hypertension (PAH) with an atrial septal defect (ASD).

Retrospectively, we performed a pulmonary wedge angiography, and hypoplasia of the right pulmonary artery was observed (Figure 2D).

We consulted a cardiac surgeon to look for any indications for repair of the shunt defect. Ahead of this, we had stared to administer vasodilators.

Four months later, we performed right heart catheterization again with macitentan 10 mg/day and riociguat 1.5 mg/day. Although the PAP went up to 68/20 (38) mmHg, the Qp/Qs (pulmonary blood flow/systemic blood flow) ratio by 100% O₂ inhalation was 1.572 (Table 2). Considering the value of the Qp/Qs ratio, Eisenmenger's syndrome was not detected. Therefore, we decided to continue with medical therapy, after which we would consider closure of the shunt hole using a catheter.

DISCUSSION

We encountered a case of PH which had unique SPECT/CT imaging findings, showing localized subpleural perfusion. To the best of our knowledge, this is the first report of such SPECT/CT imaging for screening for pulmonary vascular diseases. There has been a report of single-centre retrospective observational study evaluating V/Q SPECT findings in PAH patients. However, this pattern is completely different from that in our case.6 Furthermore, there are no other typical diseases that manifest with these findings.7 For reference, we present the SPECT/CT images of a typical case of idiopathic PAH patient without ASD, endometriosis and the history of pneumothorax or thoracic surgery (Figure 2E).

First, lobectomy might have affected SPECT findings: The operation for catamenial pneumothorax was performed only on the right side, while the abnormal accumulation on SPECT was bilateral; hence, this finding was contradictory.

Second, the possibility of presence of abnormal blood vessels in the chest wall caused by pre-existing endometriosis might have affected SPECT findings: Blood flow of abnormal blood vessels due to endometriosis is usually supplied from the systemic circulation in the chest wall to the subpleural lung parenchyma. Therefore, it might not be a cause of increased accumulation of 99mTc-MAA. Furthermore, we might consider the possibility of presence of abnormal blood vessels due to other factors. However, contrast-enhanced CT could detect obvious chest wall abnormalities or collateral circulation from the systemic circulation.

Third, due to morphological developmental abnormalities associated with ASD, peripheral pulmonary circulation might have affected SPECT findings: The clinical course in this case showed that abnormal development of pulmonary arteries existed, which is consistent with the wedge angiography image and the current blood flow SPECT/CT findings. It might be suggested that SPECT/CT image or the pulmonary wedge angiography would be helpful in determining effectiveness of treatment with vasodilators. However, SPECT/CT image was difficult to evaluate immediately due to various circumstances, which might be a limitation to this report.

The planar V/Q lung scanning, a two-dimensional technique, has been commonly performed in many institutions. However, it has limitations, especially related to the overlap of anatomic segments.5 On the other hand, SPECT is routinely used in the field of nuclear medicine because of its ability to provide images in three dimensions. SPECT has higher sensitivity compared with only planar V/Q lung imaging, and its outcomes have confirmed a high negative predictive value regarding the exclusion of pulmonary embolism (PE).4 There are various diseases other than PE for which lung SPECT/CT is useful, for example, predicting post-operative lung function after lung resection in patients with lung cancer, modifying radiotherapy fields to minimize radiation exposure to functioning lungs, demonstrating regional changes of V/Q in asthma.5, 7

There are no reports with SPECT/CT image of accumulation just below the pleura so far. Further reports on SPECT/CT imaging findings in cases with similar findings are awaited.

ACKNOWLEDGMENT

We would like to thank Editage (www.editage.com) for English language editing.

    CONFLICT OF INTEREST

    None declared.

    AUTHOR CONTRIBUTION

    Yuri Suzuki and Ayumi Sekine wrote the manuscript. Yuri Suzuki, Ayumi Sekine, Akira Nishiyama, Toshihiko Sugiura, Nobuhiro Tanabe, Yuri Isaka, Yaeko Hashimoto, Tadasu Okaya, Ayaka Kuriyama, Jun Nagata, Ayako Shigeta and Seiichiro Sakao were involved in the acquisition and interpretation of the data. Koichiro Tatsumi and Takuji Suzuki provided expertise and feedback. All authors drafted the article, revised it critically for important intellectual content and approved the final version to be submitted.

    ETHICS STATEMENT

    Appropriate written informed consent was obtained for publication of this case report and accompanying images.

      The full text of this article hosted at iucr.org is unavailable due to technical difficulties.